Related references
Note: Only part of the references are listed.Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas
Emilie T. E. Gross et al.
ONCOIMMUNOLOGY (2019)
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
Chipman R. G. Stroud et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?
Monica Mangoni et al.
RADIOLOGIA MEDICA (2019)
CD248: A therapeutic target in cancer and fibrotic diseases
Beverly A. Teicher
Oncotarget (2019)
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
Marie-Francoise Heymann et al.
CELLULAR IMMUNOLOGY (2019)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma (vol 175, 998.e1 , 2018)
Moshe Sade-Feldman et al.
CELL (2019)
Targeting chromatin complexes in fusion protein-driven malignancies
Gerard L. Brien et al.
NATURE REVIEWS CANCER (2019)
Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
Christian Spurny et al.
PEDIATRIC BLOOD & CANCER (2018)
MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling
Xianglu Ji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
PD-L1 assessment in pediatric rhabdomyosarcoma: a pilot study
Giulia Bertolini et al.
BMC CANCER (2018)
Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation
Maryam Aghighi et al.
CLINICAL CANCER RESEARCH (2018)
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
Y. Guo et al.
EUROPEAN JOURNAL OF CANCER (2018)
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
Haidong Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
Sandra P. D'Angelo et al.
LANCET ONCOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
Gordana Vlahovic et al.
ONCOLOGIST (2018)
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
Christian Spurny et al.
Oncotarget (2018)
CD99 at the crossroads of physiology and pathology
Michela Pasello et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
Nicholas L. Denton et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma
Milcah C. Scott et al.
CANCER RESEARCH (2018)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
Sareetha Kailayangiri et al.
ONCOIMMUNOLOGY (2017)
Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery
Liliana Vasquez et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
Cristina Meazza et al.
MEDICAL ONCOLOGY (2017)
Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children
Michael Merker et al.
ONCOTARGET (2017)
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
Nicola Mitwasi et al.
ONCOTARGET (2017)
Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
Kristy Pilbeam et al.
Oncotarget (2017)
The neoepitope landscape in pediatric cancers
Ti-Cheng Chang et al.
GENOME MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors
Vivek Verma et al.
FRONTIERS IN ONCOLOGY (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript
Patrick J. Grohar et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
T-Cell Infiltration and Clonality Correlate With Programmed Cell Death Protein 1 and Programmed Death-Ligand 1 Expression in Patients With Soft Tissue Sarcomas
Seth M. Pollack et al.
CANCER (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
RANK-RANKL signalling in cancer
Nathalie Renema et al.
BIOSCIENCE REPORTS (2016)
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
Matt L. Harlow et al.
CANCER RESEARCH (2016)
Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
Nicola J. Mason et al.
CLINICAL CANCER RESEARCH (2016)
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor
Christy L. Osgood et al.
CLINICAL CANCER RESEARCH (2016)
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2016)
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
Konstantin Dobrenkov et al.
PEDIATRIC BLOOD & CANCER (2016)
Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication
Krishna C. Vallabhaneni et al.
PLOS ONE (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Deepa K. Krishnadas et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
John M. Goldberg et al.
CLINICAL CANCER RESEARCH (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study
Benedikt Fritzsching et al.
ONCOIMMUNOLOGY (2015)
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
Vincent I. Poon et al.
CLINICAL SARCOMA RESEARCH (2015)
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
Sun Min Lim et al.
CANCER RESEARCH AND TREATMENT (2015)
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Patients With Osteosarcoma
Michael Roth et al.
CANCER (2014)
Remarkable regression of a lung recurrence from an undifferentiated embryonal sarcoma of the liver treated with a DC vaccine combined with immune cells: A case report
Shangyun Xie et al.
CELLULAR IMMUNOLOGY (2014)
Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
Savita Sankar et al.
CLINICAL CANCER RESEARCH (2014)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Genomic Landscape of Pediatric Ewing Sarcoma
Brian D. Crompton et al.
CANCER DISCOVERY (2014)
Targeting the DNA Repair Pathway in Ewing Sarcoma
Elizabeth Stewart et al.
CELL REPORTS (2014)
Characterization of Ewing sarcoma associated cancer/testis antigens
Dorothea E. Mahlendorf et al.
CANCER BIOLOGY & THERAPY (2013)
Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
Nourredine Himoudi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Phase I Trial of bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell Vaccine (FANG) in Advanced Cancer
Neil Senzer et al.
MOLECULAR THERAPY (2012)
Characteristics of human Ewing/PNET sarcoma models
Beverly A. Teicher et al.
ANNALS OF SAUDI MEDICINE (2011)
Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
Pedro J. Beltran et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
Nabil Ahmed et al.
MOLECULAR THERAPY (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors
Aiko Suminoe et al.
PEDIATRIC TRANSPLANTATION (2009)
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma - A retrospective analysis of response and survival in patients treated in the Surgery Branch at the National Cancer Institute between 1986 and 2006
Jacob A. Klapper et al.
CANCER (2008)
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
Crystal L. Mackall et al.
CLINICAL CANCER RESEARCH (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter-institute NIH study
R Dagher et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Share Paper
